title: Quantitative Protein Profiling of Chlamydia trachomatis Growth Forms Reveals Defense Strategies Against Tryptophan Starvation.
abstract: Chlamydia trachomatis is one of the most common sexually transmitted bacterial pathogens in humans. The infection is often asymptomatic and can lead to chronic manifestations. The infectious elementary body and the replicating reticulate body are the two growth forms in the normal developmental cycle. Under the influence of interferon-γ, the normal cycle is disrupted because of tryptophan degradation, leading to a third persistent form, the aberrant reticulate body.For the genital strain C. trachomatis D/UW-3/CX we established a quantitative, label-free proteomic approach, and identified in total 655 out of 903 (73%) predicted proteins, allowing the first quantitative comparison of all three growth forms. Inclusion membrane proteins and proteins involved in translation were more abundant in the reticulate body (RB)1and aberrant reticulate body (ARB) forms, whereas proteins of the type III Secretion System and the cell envelope were more abundant in the elementary body (EB) form, reflecting the need for these proteins to establish infection and for host interactions.In the interferon-γ induced ARB proteome, the tryptophan synthase subunits were identified as biomarkers with a strong increase from less than 0.05% to 9% of the total protein content, reflecting an inherent defense strategy for the pathogen to escape interferon-γ mediated immune pressure. Furthermore, the total tryptophan content in the ARB form was 1.9-fold lower compared with the EB form, and we demonstrate that modulation of the protein repertoire toward lower abundance of proteins with high tryptophan content, is a mechanism which contributes to establish and maintain chlamydial persistence. Thus, quantitative proteomics provides insights in the Chlamydia defense mechanisms to escape interferon-γ mediated immune pressure.
authors: From the ‡Department of Autoimmunology and Biomarkers, Statens Serum Institut, DK 2300 Copenhagen, Denmark.
authors: Ole
authors: O
authors: Østergaard
authors: §Department of Infectious Disease Immunology, Statens Serum Institut, DK 2300 Copenhagen, Denmark.
authors: Frank
authors: F
authors: Follmann
authors: §Department of Infectious Disease Immunology, Statens Serum Institut, DK 2300 Copenhagen, Denmark.
authors: Anja W
authors: AW
authors: Olsen
authors: From the ‡Department of Autoimmunology and Biomarkers, Statens Serum Institut, DK 2300 Copenhagen, Denmark.
authors: Niels H
authors: NH
authors: Heegaard
authors: §Department of Infectious Disease Immunology, Statens Serum Institut, DK 2300 Copenhagen, Denmark.
authors: Peter
authors: P
authors: Andersen
authors: §Department of Infectious Disease Immunology, Statens Serum Institut, DK 2300 Copenhagen, Denmark idr@ssi.dk.
authors: Ida
authors: I
authors: Rosenkrands
mesh_terms: D001426:Bacterial Proteins / Q000378:metabolism*; D002692:Chlamydia trachomatis / Q000187:drug effects / Q000502:physiology*; D002853:Chromatography, Liquid; D015964:Gene Expression Regulation, Bacterial / Q000187:drug effects; D006367:HeLa Cells; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology*; D040901:Proteomics / Q000379:methods*; D053719:Tandem Mass Spectrometry; D014364:Tryptophan / Q000378:metabolism*
chemical_list: D001426:Bacterial Proteins; D007371:Interferon-gamma; D014364:Tryptophan